In vitro and in vivo activity of colistin-nitroxoline combination against polymyxin heteroresistant carbapenem-resistant Klebsiella pneumoniae. [PDF]
Chen X +5 more
europepmc +1 more source
Experimental evolution under colistin selection increases colistin minimum inhibitory concentration (MIC) without detectable collateral MIC shifts in Escherichia coli ATCC 25922. [PDF]
Kerek Á +7 more
europepmc +1 more source
Persistence and Risk Assessment of Biofilm-Forming MDR and XDR Bacteria on Non-Poultry Meat Contact Surfaces in Wah Cantt, Pakistan. [PDF]
Shakoor L, Naz S, Rashid A, Idrees M.
europepmc +1 more source
A Novel Antimicrobial Peptide Displaying Broad-Spectrum Activity Against Pan-Resistant Pathogens and Low Propensity for Resistance Development. [PDF]
Temur BZ +7 more
europepmc +1 more source
Microbiological Profile of Pathogens Among Patients at a Tertiary Care Hospital in Mumbai, India. [PDF]
Ranade G, Gumaste PD.
europepmc +1 more source
Redox biology underlying the efficacy and toxicity of colistin as a last-resort antibiotic. [PDF]
Soria-Herrera RJ +3 more
europepmc +1 more source
Sulbactam-Durlobactam for Carbapenem-resistant <i>Acinetobacter baumannii</i> in India: Does Local Molecular Epidemiology Support Current Guideline Recommendations? [PDF]
Mukkelli VG, Gupta R.
europepmc +1 more source
When might we consider using the newer β-lactam agents as empirical therapy against presumed carbapenem-resistant gram-negative infections? [PDF]
Assimakopoulos SF +4 more
europepmc +1 more source
In Silico Mutational Analysis of Two-Component System Genes Associated with Colistin Resistance in Clinical <i>Pseudomonas aeruginosa</i> Isolates from Peshawar. [PDF]
Ahmad B +10 more
europepmc +1 more source
Carbapenem-resistant Gram-negative pathogens: molecular epidemiology, diagnostic advances, and emerging therapeutic strategies. [PDF]
Khan M, Patil P, Rathored J.
europepmc +1 more source

